TCIM
FOLD

TIAA CREF Investment Management’s Amicus Therapeutics FOLD Stock Holding History

TIAA CREF Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$9.05M Buy
665,764
+90,177
+16% +$1.1M 0.01% 1083
2018
Q4 		$5.51M Sell
575,587
-9,379
-2% -$103K ﹤0.01% 1317
2018
Q3 		$7.07M Buy
584,966
+24,189
+4% +$338K ﹤0.01% 1340
2018
Q2 		$8.76M Buy
560,777
+2,694
+0.5% +$40.7K 0.01% 1234
2018
Q1 		$8.39M Buy
558,083
+28,415
+5% +$432K 0.01% 1225
2017
Q4 		$7.62M Sell
529,668
-20,520
-4% -$282K 0.01% 1324
2017
Q3 		$8.3M Buy
550,188
+62,437
+13% +$826K 0.01% 1270
2017
Q2 		$4.91M Buy
487,751
+52,136
+12% +$420K ﹤0.01% 1609
2017
Q1 		$3.11M Buy
435,615
+27,443
+7% +$174K ﹤0.01% 1879
2016
Q4 		$2.03M Sell
408,172
-12,664
-3% -$87.6K ﹤0.01% 2182
2016
Q3 		$3.11K Buy
420,836
+28,385
+7% +$192K ﹤0.01% 1909
2016
Q2 		$2.14M Buy
392,451
+39,386
+11% +$275K ﹤0.01% 2073
2016
Q1 		$2.98M Sell
353,065
-4,855
-1% -$34.4K ﹤0.01% 1853
2015
Q4 		$3.47M Sell
357,920
-9,364
-3% -$84.4K ﹤0.01% 1808
2015
Q3 		$5.14M Buy
367,284
+38,507
+12% +$604K ﹤0.01% 1520
2015
Q2 		$4.65M Buy
+328,777
New +$3.95M ﹤0.01% 1736
2014
Q2 		– Sell
-123,481
Closed -$256K – 3132
2014
Q1 		$256K Hold
123,481
– – ﹤0.01% 3056
2013
Q4 		$290K Hold
123,481
– – ﹤0.01% 3056
2013
Q3 		$286K Buy
123,481
+5,126
+4% +$12.9K ﹤0.01% 3029
2013
Q2 		$276K Buy
+118,355
New +$364K ﹤0.01% 3031

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIAA CREF Investment Management's FOLD Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Amicus Therapeutics (FOLD) stake by 16% in Q1 2019, buying an estimated $1.1M and bringing the position to 665,764 shares worth $9.05M. The position accounts for 0.01% of the portfolio, ranked #1083.

TIAA CREF Investment Management first reported a position in FOLD in Q2 2013 and has held it in 20 quarters since. 205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

  • TIAA CREF Investment Management held 665,764 shares of Amicus Therapeutics worth $9.05M as of Q1 2019.
  • TIAA CREF Investment Management bought 90,177 Amicus Therapeutics shares in Q1 2019, an estimated $1.1M.
  • Amicus Therapeutics made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1083 holding.
  • TIAA CREF Investment Management first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 20 quarters since.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.